The PRIME collaboration
The PRecision Medicine for Diabetic Individuals: A joint Malaysia-UK Effort (PRIME) research project is funded by the UK-Malaysia Joint Partnership for Non-Communicable Diseases (NCD) grant scheme awarded by the Medical Research Council (MRC) Newton-Ungku Omar Fund. This project is a collaborative effort between the UKM Medical Molecular Biology Institute (UMBI) and the University of Dundee (UK). The principal investigators are Prof. Dr. Chim C Lang (University of Dundee) and Prof. Datuk Dr. A Rahman A Jamal (UMBI). The PRIME Partnership programme aims to develop interdisciplinary expertise and build partnerships amongst physician-scientists, genetic epidemiologists, big data analysts, machine learning scientists, and policymakers to cohesively deliver multi-level strategies to augment precision medicine for Type 2 Diabetes (T2D) in Malaysia. Read more…
Working Plans (WPs)
-
A Global Development Initiative
Establishment of an interdisciplinary research partnership between Dundee and Malaysia
-
PRIME Cohort
Establishment of the PRIME Cohort, to consolidate Malaysian’s clinical data and to compare it with Scotland’s
-
Southeast Asian Haplotype
Generation of Southeast Asian Haplotype via GWAS
-
Retinome
A sub-study on the diabetic retina via digital retinal imaging -
Combinatorial Analysis
A more accurate analysis using clinical, retinal, and genomic information
-
Translational and Evidence-based Research
Comparison of the outcomes between PRIME (Malaysia), GoDARTS (UK), and INSPIRED (India) cohorts, respectively
ACTIVITIES
